Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity. - Wikidata - awgldk - TriplyDB

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.

http://www.wikidata.org/entity/Q34519826

about

Invariant NKT cells as novel targets for immunotherapy in solid tumors NKT cell networks in the regulation of tumor immunity The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Lipid antigens in immunity.Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.Delicate balance among three types of T cells in concurrent regulation of tumor immunity.β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors.Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.Synthesis of a 2"-deoxy-β-GalCer NKT cell adjuvants in therapeutic vaccines against hematological cancers.Non-glycosidic compounds can stimulate both human and mouse iNKT cells.Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity-Suppression of Tumor Immunity in the Intestine.The Use of a Semi-Automated System to Measure Mouse Natural Killer T (NKT) Cell Activation by Lipid-Loaded Dendritic Cells.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.Tissue-Specific Roles of NKT Cells in Tumor Immunity

P2860

Q21284987-DBAA8632-84D5-4C1F-A7AC-EECA41E5D5A2 Q26866223-01CEBC31-4DCB-4057-8830-090EBE98CBFF Q27027556-8E3C2E3B-1845-4317-A53D-24C0FAEBAF44 Q34025822-92AD2349-F8C4-4C8C-BE1F-7AAFCD750DB5 Q35622939-3D3306FF-48F3-43DA-8EA7-523505E0E589 Q36005345-4FA33268-EE17-4581-A5AE-86FAE912C9A8 Q36568780-49492A70-7FB0-4195-AF2E-0DC29607D46E Q36755513-284BB408-2C0A-4CC0-801D-D2F503702465 Q37285232-5832EADD-A512-417A-A806-63BD02F83D1F Q37902828-BF38F847-3C7E-4A66-87A3-994AE8AE5BFC Q37986831-78664013-4E17-4502-A51F-4963D3973FF6 Q38734173-F3B2EDF3-EC35-4090-8BE0-86532C106806 Q38890717-55EC0EE2-4046-4588-B2D6-EDE02FEF1735 Q39958212-74858966-BC97-45EF-B798-8E0740736AE3 Q42061552-7C0267AC-2E31-4E2D-BAE6-F82BEF4A0CEB Q42608724-2EF3AC40-EE35-4491-802C-21A83C26AEDC Q45966276-CB44918F-ADD4-4D54-A476-E7D4283B0597 Q49452437-7E7DDA06-BF58-403A-A64B-FBEAB5BA9477 Q51094863-EEBFE185-6003-44FF-B5A7-743066B1FE4C Q55094012-F14D20C7-62BC-4107-9725-2997B9F373B5 Q58777562-A06FC077-6411-4613-A868-AA6B450025CB

P2860

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.

http://www.wikidata.org/entity/Q34519826

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@ast

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@en

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@nl

type

label

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@ast

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@en

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@nl

prefLabel

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@ast

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@en

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@nl

P1433

Q34519826-19BA8E11-0409-472F-B1CF-6B59AEA2CADA

P1476

Q34519826-683B93AA-14BE-4744-9DE2-53A5C3BF0196

P2093

Q34519826-2A5D2D7B-B7B5-4790-8366-57F7BF96F123

Q34519826-50F1A81A-A163-46F3-AF1D-400D127A9A60

Q34519826-6080262F-41F5-43F4-BEB0-9EB6B2BC5EC1

Q34519826-6C903439-E081-451A-A78A-69AE4C964BD9

Q34519826-6E32F0B5-9430-43AD-BC57-867135A500CC

Q34519826-7689853E-81FD-4F36-9F37-65B56667C3EE

Q34519826-78C00070-4529-4FD2-81FA-532781A7CB99

Q34519826-8C049364-38AB-46DD-9EEA-54649157CFF4

Q34519826-92FA3B38-84F3-4543-AF17-ABEE64691BDC

Q34519826-B327D50B-F56B-4CC0-92A1-A49996F8FE6D

P2860

Q34519826-014B0A59-5F84-497F-A976-E193AF219706

Q34519826-0FA58E85-5A16-4125-9B37-9ADA4AB2DDAE

Q34519826-13B3FEC3-6B6F-4F8D-B4E5-DB07FF00221B

Q34519826-158CABB8-3FCC-4EFC-BB84-8907DD9615EB

Q34519826-15B97816-59B9-42D4-B02E-31D6692F7BA2

Q34519826-15F5F92B-848D-42AA-A910-4AFA84365EB8

Q34519826-198C7922-4F4C-41D6-9699-4CFC7FE1D8FB

Q34519826-26F093A6-5F56-4D1D-8154-97883F4867A3

Q34519826-2973BA47-9D3D-4FA9-B8AA-13632ACC7384

Q34519826-378BE83E-176A-4DE3-88FC-FA0A235A657A

P304

Q34519826-EBA9F3EF-A7DC-4044-81C8-07D79E52EB42

P31

Q34519826-B9D91A58-7A07-449D-BEA6-2DFD2D86E37A

P356

Q34519826-6A274492-4D7A-4DED-BCBC-6454354427C1

P407

Q34519826-B1E68BBF-4F55-40FA-815C-493320E7C86B

P433

Q34519826-5A979197-9E89-4B49-8DBB-A58DB631E264

P478

Q34519826-3F96E621-06C5-45BA-B661-D959481E795D

P50

Q34519826-02A5977E-A521-445B-A5B5-47F1614F83B0

Q34519826-0A66B0A9-EBF9-4070-AA5E-4E16D4E99137

Q34519826-3BE6B103-EA57-44CC-A173-20DC97A9C44E

P577

Q34519826-22C421F1-2EB9-4794-8933-35E1FDB3008D

P698

Q34519826-D0E36475-944F-4172-BEC5-10BB36E4E923

P932

Q34519826-177AE6F0-E202-445E-9CC3-791E2C859BEF

P356

P1433

Journal of Clinical Investigation

P1476

Mouse and human iNKT cell agon ...... t mechanism of tumor immunity.

@en

P2093

Bernard F Castillo

http://www.w3.org/2001/XMLSchema#string

Deborah Stewart Khursigara

http://www.w3.org/2001/XMLSchema#string

Elena Ambrosino

http://www.w3.org/2001/XMLSchema#string

Hee-Yong Kim

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Jessica J O'Konek

http://www.w3.org/2001/XMLSchema#string

Liat Izhak

http://www.w3.org/2001/XMLSchema#string

Maryam Khalili

http://www.w3.org/2001/XMLSchema#string

Masaki Terabe

http://www.w3.org/2001/XMLSchema#string

Petr Illarionov

http://www.w3.org/2001/XMLSchema#string

P2860

The role of NKT cells in tumor immunity

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

The biology of NKT cells

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

CD1 recognition by mouse NK1+ T lymphocytes

Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.

Glycolipid antigen induces long-term natural killer T cell anergy in mice.

P304

683-694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI42314

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Steven A Porcelli

P577

2011-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21245578

http://www.w3.org/2001/XMLSchema#string

P932

3026717

http://www.w3.org/2001/XMLSchema#string